Company Profile
Updated: 29-SEP-09Hemispherx Biopharma Inc.
Public Company, Headquarters Location
1617 JFK Blvd., Ste. 660, Philadelphia, PA 19103-1806, United States
(215)988-0080, (215)988-1739 fax, http://www.hemispherx.net
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Manufactures development-stage compange for RNA drugs.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
HEMISPHERX BIOPHARMA REPORTS ACQUISITION BY CHIEF FINANCIAL OFFICER BERNHARDT (Pennsylvania)
US Fed News Service, Including US State News; 12/10/2009; 303 words; WASHINGTON, Dec. 10 -- Hemispherx Biopharma Inc. (HEB), Philadelphia, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
HEMISPHERX BIOPHARMA REPORTS ACQUISITION BY SENIOR VP DICKEY (Pennsylvania)
US Fed News Service, Including US State News; 12/9/2009; 296 words; WASHINGTON, Dec. 9 -- Hemispherx BioPharma Inc. (HEB), Philadelphia, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
HEMISPHERX BIOPHARMA REPORTS ACQUISITION BY MEDICAL DIRECTOR STRAYER (Pennsylvania)
US Fed News Service, Including US State News; 12/9/2009; 299 words; WASHINGTON, Dec. 9 -- Hemispherx Biopharma Inc. (HEB), Philadelphia, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...
Research and Markets Offers Report: Hepatitis C Virus And Therapeutics
Wireless News; 12/7/2009; 516 words; ...Pharmaceuticals, Inc. (USA) - Anadys Pharmaceuticals, Inc. (USA) - Boehringer Ingelheim GmbH (Germany...GlaxoSmithKline plc (UK) - Hayashibara Biochemical Labs, Inc. (Japan) - HemispheRx Biopharma, Inc. (USA) - Human Genome Sciences (USA) - Idenix...
Hemispherx Biopharma Gets Response Letter From FDA.
Investrend; 12/4/2009; 1129 words; ...www.financialwire.net/2009/12/04/hemispherx-biopharma-gets-response-letter-from-fda/) December 4, 2009 (FinancialWire) -- Hemispherx Biopharma, Inc. (AMEX: HEB), received a Complete Response...
Recent News Articles
- Hemispherx BioPharma, Inc (AMEX:HEB) is The Top Percentage Gainer On AMEX During Morning Trading Hours.
M2 Presswire - July 20, 2009 - Audio Interview with Dr. William A. Carter, CEO. Hemispherx Biopharma, Inc. (AMEX:HEB).
M2 Presswire - June 15, 2009 - Healthcare Sector's Biggest Winners Become Biggest Losers - Hemispherx Biopharma (Amex:HEB), Novavax, Inc. (Nasdaq:NVAX), and Palomar Medical (NASDAQ:PMTI).
M2 Presswire - June 08, 2009 - Stocks to Watch: American Petro-Hunter, Inc. (OTC BB: AAPH.OB), Hemispherx Biopharma, Inc. (NYSE: HEB), Cord Blood America, Inc. (OTCBB: CBAI), NVIDIA Corporation (NASDAQ: NVDA), Palm, Inc. (NASDAQ: PALM).
M2 Presswire - May 28, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning